The establishment of the Vietnam Clinical Biology Association is a concrete step to realize one of the important policies set out by the Government in the "National Strategy on Drug Prevention and Control in Vietnam for the period 2023-2030, with a vision to 2045". That is to slow down the development of drug resistance, prevent and control the spread of drug-resistant microorganisms and infectious diseases. At the same time, the Association also contributes to ensuring that antibiotics are always available and used appropriately to effectively treat infectious diseases, helping to protect, care for, improve human health, protect the environment, and develop the country's economy and society.
Vinmec Times City International General Hospital was chosen as the headquarters of the Vietnam Clinical Biology Association, marking the recognition of its professional capacity and international standard facilities. With synchronous and modern testing equipment, along with a team of leading experts, Vinmec is not only the foundation for the establishment of the Association but also directly supports the Ministry of Health in analyzing data and publishing annual national monitoring report on drug resistance, contributing significantly to the silent epidemic prevention strategy in Vietnam.
Speaking at the event, Prof. Dr. Tran Trung Dung, General Director of Vinmec Healthcare System, said: With the responsibility of a pioneering healthcare system, Vinmec is committed to closely accompanying the Vietnam Clinical Violation Association in all professional and research activities. We are ready to mobilize resources, share knowledge and promote quality standards to contribute to improving the effectiveness of antibiotic resistance prevention nationwide.
According to Associate Professor, Dr. Doan Mai Phuong, Head of the microbiology Department, Vinmec Times City International General Hospital, Chairman of the Vietnam Clinical microbiology Association, Vietnam is among the countries with a very high resistance rate to multi-resistant bacteria that make treatment difficult. Recognizing this challenge, Vietnam has soon become one of the first 6 countries in the Asia Pacific region to develop and implement a National Action Plan on Drug Prevention and Control. This effort is highly appreciated by the international community and recognized as an important contribution to the global fight against drug resistance.
According to the Chairman of the Vietnam Clinical Biology Association, the clinical microbiology major plays a very important role in preventing antibiotic resistance. Because to detect drug-resistant microorganisms, hospitals need to have clinical microbiological testing rooms that ensure quality. Antibiotic results are evidence to choose antibiotics for effective treatment, avoid abuse and reduce the spread of resistance to drugs among microorganisms.
The Vietnam Clinical Biology Association will be the highest professional organization of the Clinical Biology industry, unifying, standardizing regulations, professional processes, and guiding the development of a system to ensure the quality of microbiological testing nationwide, aiming to meet international standards, affirmed Associate Professor, Dr. Doan Mai Phuong.
The World Health Organization's Global Monitoring System on Antibiotic Resistance and Use (WHO-GLASS) recommends that each country needs to have many international reference laboratories to ensure reliable data and support the national network. According to this orientation, Vinmec aims to build a national reference laboratory for antibiotic resistance that meets international standards.
